Literature DB >> 10747115

Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay.

F Lallemand1, N Desire, W Rozenbaum, J C Nicolas, V Marechal.   

Abstract

We have developed a quantitative real-time PCR (TaqMan) assay aimed at measuring the cellular human herpesvirus 8 (HHV-8) DNA load in various clinical samples. Standard curves were obtained by serial dilutions of a control plasmid containing both HHV-8 (ORF73 gene) and the cellular target (human albumin gene). The assay appeared to be very sensitive (100% detection rate for at least 10 copies per well) and specific and was easily reproducible (less than 3% intra-assay variability, 5% interassay variability). This method allowed us to quantify precisely the average HHV-8 copy number per cell in various persistently HHV-8-infected cell lines (BBG-1 cells, n = 200; BC-1 cells, n = 59; BCBL-1 cells, n = 70). A retrospective study was also conducted to assess the HHV-8 DNA load in 12 human immunodeficiency virus-infected patients with either Kaposi's sarcoma (KS; seven patients monitored over a 3-month period) or multicentric Castleman's disease (MCD; five patients). The HHV-8 DNA load ranged from 0 to 9,171 copies/10(6) cells in low-risk KS patients (T0, I0, S0 according to the classification of the AIDS Clinical Trials group). We also measured the viral loads in MCD patients either during symptomatic periods or during remission. The results are in agreement with previously published data, with high viral loads correlating with clinical symptoms (1.3 x 10(6) copies/10(6) cells) and low viral loads correlating with asymptomatic periods (less than 5,000 copies/10(6) cells).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747115      PMCID: PMC86453     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  22 in total

1.  Human herpesvirus 8 and Epstein Barr-virus in a cutaneous B-cell lymphoma and a malignant cell line established from the blood of an AIDS patient.

Authors:  P Morand; M Buisson; H Collandre; B Chanzy; O Genoulaz; M J Bourgeat; N Pinel; P Leclercq; D Leroux; V Marechal; L Fritsch; R Ruigrok; J M Seigneurin
Journal:  Leuk Lymphoma       Date:  1999-10

2.  Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.

Authors:  M E Ballestas; P A Chatis; K M Kaye
Journal:  Science       Date:  1999-04-23       Impact factor: 47.728

3.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.

Authors:  E Cesarman; Y Chang; P S Moore; J W Said; D M Knowles
Journal:  N Engl J Med       Date:  1995-05-04       Impact factor: 91.245

4.  Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.

Authors:  P Saiag; M Pavlovic; T Clerici; V Feauveau; J C Nicolas; D Emile; C Chastang
Journal:  AIDS       Date:  1998-11-12       Impact factor: 4.177

5.  Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.

Authors:  N Dupin; M Grandadam; V Calvez; I Gorin; J T Aubin; S Havard; F Lamy; M Leibowitch; J M Huraux; J P Escande
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

6.  Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.

Authors:  Y Q Huang; J J Li; M H Kaplan; B Poiesz; E Katabira; W C Zhang; D Feiner; A E Friedman-Kien
Journal:  Lancet       Date:  1995-03-25       Impact factor: 79.321

7.  Novel approach to quantitative polymerase chain reaction using real-time detection: application to the detection of gene amplification in breast cancer.

Authors:  I Bièche; M Olivi; M H Champème; D Vidaud; R Lidereau; M Vidaud
Journal:  Int J Cancer       Date:  1998-11-23       Impact factor: 7.396

8.  Human herpesvirus 8 DNA load in leukocytes of human immunodeficiency virus-infected subjects: correlation with the presence of Kaposi's sarcoma and response to anticytomegalovirus therapy.

Authors:  G Boivin; A Gaudreau; E Toma; R Lalonde; J P Routy; G Murray; J Handfield; M G Bergeron
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

9.  In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences.

Authors:  E Cesarman; P S Moore; P H Rao; G Inghirami; D M Knowles; Y Chang
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

10.  Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease.

Authors:  J Soulier; L Grollet; E Oksenhendler; P Cacoub; D Cazals-Hatem; P Babinet; M F d'Agay; J P Clauvel; M Raphael; L Degos
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113

View more
  45 in total

1.  Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds.

Authors:  S Garcia; J M Crance; A Billecocq; A Peinnequin; A Jouan; M Bouloy; D Garin
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 2.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

3.  Human herpesvirus 8 load in matched serum and plasma samples of patients with AIDS-associated Kaposi's sarcoma.

Authors:  Abeltje M Polstra; Remco Van Den Burg; Jaap Goudsmit; Marion Cornelissen
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

4.  Characterization of human herpes virus 8 genotypes in Kaposi's sarcoma patients in Tehran, Iran.

Authors:  Kayhan Azadmanesh; Zeinab Sadat Norouzfar; Amir Sohrabi; Zahra Safaie-Naraghi; Afshin Moradi; Parichehre Yaghmaei; Mona Masoumeh Naraghi; Arash Arashkia; Ali Eslamifar
Journal:  Int J Mol Epidemiol Genet       Date:  2012-05-15

5.  Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells.

Authors:  Xuezhong Cai; Shihua Lu; Zhihong Zhang; Carlos M Gonzalez; Blossom Damania; Bryan R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-30       Impact factor: 11.205

6.  A dynamic model for induced reactivation of latent virus.

Authors:  G M Kepler; H K Nguyen; J Webster-Cyriaque; H T Banks
Journal:  J Theor Biol       Date:  2006-09-07       Impact factor: 2.691

7.  K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function.

Authors:  Tyson V Sharp; Hsei-Wei Wang; Andrew Koumi; Daniel Hollyman; Yoshio Endo; Hongtao Ye; Ming-Qing Du; Chris Boshoff
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

8.  Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic.

Authors:  Renan Duprez; Eric Kassa-Kelembho; Sabine Plancoulaine; Josette Brière; Mireille Fossi; Léon Kobangue; Pierre Minsart; Michel Huerre; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

9.  Realtime PCR is more sensitive than multiplex PCR for diagnosis and serotyping in children with culture negative pneumococcal invasive disease.

Authors:  Chiara Azzari; Maria Moriondo; Giuseppe Indolfi; Martina Cortimiglia; Clementina Canessa; Laura Becciolini; Francesca Lippi; Maurizio de Martino; Massimo Resti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

10.  Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection.

Authors:  Elisa Martró; Michael J Cannon; Sheila C Dollard; Thomas J Spira; A Scott Laney; Chin-Yih Ou; Philip E Pellett
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.